141 related articles for article (PubMed ID: 38926633)
1. FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer.
Lorito N; Subbiani A; Smiriglia A; Bacci M; Bonechi F; Tronci L; Romano E; Corrado A; Longo DL; Iozzo M; Ippolito L; Comito G; Giannoni E; Meattini I; Avgustinova A; Chiarugi P; Bachi A; Morandi A
EMBO Mol Med; 2024 Jun; ():. PubMed ID: 38926633
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.
Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S
Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer.
Wang Y; Sun Y; Wang F; Wang H; Hu J
Biomed Pharmacother; 2023 Dec; 169():115866. PubMed ID: 37951026
[TBL] [Abstract][Full Text] [Related]
4. Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer.
Lee JY; Nam M; Son HY; Hyun K; Jang SY; Kim JW; Kim MW; Jung Y; Jang E; Yoon SJ; Kim J; Kim J; Seo J; Min JK; Oh KJ; Han BS; Kim WK; Bae KH; Song J; Kim J; Huh YM; Hwang GS; Lee EW; Lee SC
Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32433-32442. PubMed ID: 33288688
[TBL] [Abstract][Full Text] [Related]
5. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells.
Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W
Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043
[TBL] [Abstract][Full Text] [Related]
6. Disruption of polyunsaturated fatty acid biosynthesis drives STING-dependent acute myeloid leukemia cell maturation and death.
Kanefsky J; Basse M; Sokei J; di Martino O; Valin L; Jaspers Y; Martinez E; Huhn J; Di Marcantonio D; Magee JA; Goldman AR; Tang HY; Ferraro F; Kemp S; Wiest DL; Sykes SM
J Biol Chem; 2024 May; 300(5):107214. PubMed ID: 38522521
[TBL] [Abstract][Full Text] [Related]
7. Can Iron and Polyunsaturated Fatty Acid Supplementation Induce Ferroptosis?
Delesderrier E; Monteiro JDC; Freitas S; Pinheiro IC; Batista MS; Citelli M
Cell Physiol Biochem; 2023 Apr; 57(S1):24-41. PubMed ID: 37087689
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis as a promising targeted therapy for triple negative breast cancer.
Mokhtarpour K; Razi S; Rezaei N
Breast Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38874688
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis: the emerging player in remodeling triple-negative breast cancer.
Li J; He D; Li S; Xiao J; Zhu Z
Front Immunol; 2023; 14():1284057. PubMed ID: 37928550
[TBL] [Abstract][Full Text] [Related]
10. Nano-inducer of ferroptosis for targeted chemotherapy of human triple negative breast carcinoma.
Shetake NG; Das SK; Kumar A; Pandey BN
Biomater Adv; 2024 Jul; 161():213868. PubMed ID: 38677038
[TBL] [Abstract][Full Text] [Related]
11. SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells.
Xuan Y; Wang H; Yung MM; Chen F; Chan WS; Chan YS; Tsui SK; Ngan HY; Chan KK; Chan DW
Theranostics; 2022; 12(7):3534-3552. PubMed ID: 35547771
[No Abstract] [Full Text] [Related]
12. Isocitrate dehydrogenase 2 regulates the proliferation of triple-negative breast cancer through the ferroptosis pathway.
Zhang C; Zhou Y; Chen T; Bhushan S; Sun S; Zhang P; Yang Y
Sci Rep; 2024 Feb; 14(1):4732. PubMed ID: 38413708
[TBL] [Abstract][Full Text] [Related]
13. A tale of two lipids: Lipid unsaturation commands ferroptosis sensitivity.
Rodencal J; Dixon SJ
Proteomics; 2023 Mar; 23(6):e2100308. PubMed ID: 36398995
[TBL] [Abstract][Full Text] [Related]
14. Geometrical isomerization of arachidonic acid during lipid peroxidation interferes with ferroptosis.
Hirata Y; Ferreri C; Yamada Y; Inoue A; Sansone A; Vetica F; Suzuki W; Takano S; Noguchi T; Matsuzawa A; Chatgilialoglu C
Free Radic Biol Med; 2023 Aug; 204():374-384. PubMed ID: 37257700
[TBL] [Abstract][Full Text] [Related]
15. Integrated profiling uncovers prognostic, immunological, and pharmacogenomic features of ferroptosis in triple-negative breast cancer.
Fang K; Xu Z; Jiang S; Yan C; Tang D; Huang Y
Front Immunol; 2022; 13():985861. PubMed ID: 36505498
[TBL] [Abstract][Full Text] [Related]
16. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects.
Dierge E; Debock E; Guilbaud C; Corbet C; Mignolet E; Mignard L; Bastien E; Dessy C; Larondelle Y; Feron O
Cell Metab; 2021 Aug; 33(8):1701-1715.e5. PubMed ID: 34118189
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis and Triple-Negative Breast Cancer: A Systematic Overview of Prognostic Insights and Therapeutic Potential.
Khan M; Sunkara V; Yadav M; Bokhari SFH; Rehman A; Maheen A; Shehryar A; Chilla SP; Nasir M; Niaz H; Choudhari J; Anika NN; Amir M
Cureus; 2024 Jan; 16(1):e51719. PubMed ID: 38318597
[TBL] [Abstract][Full Text] [Related]
18. Polyunsaturated Fatty Acids Drive Lipid Peroxidation during Ferroptosis.
Mortensen MS; Ruiz J; Watts JL
Cells; 2023 Mar; 12(5):. PubMed ID: 36899940
[TBL] [Abstract][Full Text] [Related]
19. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles.
Zhang J; Zhou K; Lin J; Yao X; Ju D; Zeng X; Pang Z; Yang W
Biomaterials; 2023 Dec; 303():122395. PubMed ID: 37988899
[TBL] [Abstract][Full Text] [Related]
20. Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer.
Zhang Z; Lu M; Chen C; Tong X; Li Y; Yang K; Lv H; Xu J; Qin L
Theranostics; 2021; 11(7):3167-3182. PubMed ID: 33537080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
